TAM
APLS

Tyers Asset Management’s Apellis Pharmaceuticals APLS Stock Holding History

Tyers Asset Management’s Portfolio APLS Stock Details APLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$31K Buy
+1,288
New +$35.5K ﹤0.01% 934
2019
Q1 		– Sell
-2,268
Closed -$30K – 985
2018
Q4 		$30K Buy
+2,268
New +$34.8K ﹤0.01% 905

Other funds holding APLS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Tyers Asset Management's APLS Position: Q3 2019 in Review

Tyers Asset Management opened a new position in Apellis Pharmaceuticals (APLS) in Q3 2019: 1,288 shares worth $31K. The stake represents ﹤0.01% of the portfolio and ranks #934 among its holdings. This is a return to the name: Tyers Asset Management previously reported a position in APLS as recently as Q4 2018.

Tyers Asset Management first reported a position in APLS in Q4 2018 and has held it in 2 quarters since. 129 funds tracked by Wall St. Rank hold APLS as of Q3 2019.

  • Tyers Asset Management held 1,288 shares of Apellis Pharmaceuticals worth $31K as of Q3 2019.
  • Apellis Pharmaceuticals was a new Tyers Asset Management position in Q3 2019.
  • Apellis Pharmaceuticals made up ﹤0.01% of Tyers Asset Management's portfolio in Q3 2019, its #934 holding.
  • Tyers Asset Management first reported a position in Apellis Pharmaceuticals in Q4 2018 and has held it in 2 quarters since.
  • 129 funds tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q3 2019.

Based on Tyers Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.